Annual report pursuant to Section 13 and 15(d)

Document and Entity Information

v3.22.2.2
Document and Entity Information - USD ($)
$ in Millions
 12 Months Ended
Jun. 30, 2022
Sep. 26, 2022
Dec. 31, 2021
Cover [Abstract]      
Document Type 10-K    
Amendment Flag false    
Document Period End Date Jun. 30, 2022    
Document Fiscal Year Focus 2022    
Document Fiscal Period Focus FY    
Trading Symbol KTRA    
Title of 12(b) Security Common Stock    
Security Exchange Name NASDAQ    
Entity Registrant Name Kintara Therapeutics, Inc.    
Entity Central Index Key 0001498382    
Current Fiscal Year End Date --06-30    
Entity Well-known Seasoned Issuer No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Voluntary Filers No    
Entity Filer Category Non-accelerated Filer    
Entity Public Float     $ 24.7
Entity Common Stock, Shares Outstanding   80,807,316  
Entity Shell Company false    
Entity Small Business true    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag false    
Entity Incorporation, State or Country Code NV    
Entity File Number 001-37823    
Entity Tax Identification Number 99-0360497    
Entity Address, Address Line One 9920 Pacific Heights Blvd    
Entity Address, Address Line Two Suite 150    
Entity Address, City or Town San Diego    
Entity Address, State or Province CA    
Entity Address, Postal Zip Code 92121    
City Area Code 858    
Local Phone Number 350-4364    
Document Annual Report true    
Document Transition Report false    
Auditor Name Marcum LLP    
Auditor Firm ID 688    
Auditor Location San Francisco, CA    
Documents Incorporated by Reference None